Keywords: ImmunoCellular Therapeutics, Roche, Licensing, cancer

ImmunoCellular in upto $32 million deal with Roche

Article | 10 September 2009

USA-based ImmunoCellular Therapeutics says that it has entered into a research and license option agreement regarding its ICT-69 antibody with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing